Lifecore Biomedical (LFCR) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

5

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.12

Median Target+51.70%

$6.25

Potential upside vs current price

DCF Value-389.51%

-$11.93

Potential downside vs current price

Current Stock Price

$4.12

Median Target+51.70%

$6.25

Potential upside vs current price

DCF Value-389.51%

-$11.93

Potential downside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

5

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.12

Median Target+51.70%

$6.25

Potential upside vs current price

DCF Value-389.51%

-$11.93

Potential downside vs current price

Current Stock Price

$4.12

Median Target+51.70%

$6.25

Potential upside vs current price

DCF Value-389.51%

-$11.93

Potential downside vs current price

Lifecore Biomedical, Inc.